- Home
- CLDX vs TRS Comparison
CLDX vs TRS Comparison
Compare CLDX & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- TRS
- Stock Information
- Founded
- CLDX N/A
- TRS 1986
- Country
- CLDX United States
- TRS United States
- Employees
- CLDX N/A
- TRS N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TRS Industrial Specialties
- Sector
- CLDX Health Care
- TRS Industrials
- Exchange
- CLDX Nasdaq
- TRS Nasdaq
- Market Cap
- CLDX 1.6B
- TRS 1.5B
- IPO Year
- CLDX 2008
- TRS 2007
- Fundamental
- Price
- CLDX $26.22
- TRS $37.14
- Analyst Decision
- CLDX Strong Buy
- TRS Strong Buy
- Analyst Count
- CLDX 8
- TRS 2
- Target Price
- CLDX $46.13
- TRS $45.00
- AVG Volume (30 Days)
- CLDX 1.1M
- TRS 447.9K
- Earning Date
- CLDX 11-05-2025
- TRS 10-28-2025
- Dividend Yield
- CLDX N/A
- TRS 0.43%
- EPS Growth
- CLDX N/A
- TRS N/A
- EPS
- CLDX N/A
- TRS 0.91
- Revenue
- CLDX $5,790,000.00
- TRS $973,840,000.00
- Revenue This Year
- CLDX N/A
- TRS $11.03
- Revenue Next Year
- CLDX N/A
- TRS $6.13
- P/E Ratio
- CLDX N/A
- TRS $40.83
- Revenue Growth
- CLDX N/A
- TRS 6.72
- 52 Week Low
- CLDX $14.40
- TRS $19.33
- 52 Week High
- CLDX $31.66
- TRS $40.34
- Technical
- Relative Strength Index (RSI)
- CLDX 60.30
- TRS 42.60
- Support Level
- CLDX $24.49
- TRS $36.95
- Resistance Level
- CLDX $26.90
- TRS $38.07
- Average True Range (ATR)
- CLDX 1.00
- TRS 0.92
- MACD
- CLDX 0.07
- TRS -0.41
- Stochastic Oscillator
- CLDX 79.27
- TRS 8.45
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.